Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,700 | $65.90 | $243,821.86 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998,139 F5 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $65.49 to $66.32. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 700 | $64.70 | $45,291.05 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,001,839 F5 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $64.22 to $64.96. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,890 | $68.49 | $129,450.83 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002,539 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 20:12 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,359 | $67.93 | $92,316.60 |
DisclosureSEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,004,429 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 02:13 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 106 | $68.49 | $7,260.21 |
DisclosureSEC source: 0001562180-21-000762 · primarydocument.xml · nonDerivative · entry 2 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,834 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 518 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,822 restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 02:13 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 76 | $67.93 | $5,162.66 |
DisclosureSEC source: 0001562180-21-000762 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,940 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 518 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,822 restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:04 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 77 | $68.49 | $5,273.92 |
DisclosureSEC source: 0001562180-21-000755 · primarydocument.xml · nonDerivative · entry 2 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,367 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 380 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,181 restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 01:04 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 56 | $67.93 | $3,804.07 |
DisclosureSEC source: 0001562180-21-000755 · primarydocument.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,444 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 380 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,181 restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 00:56 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 61 | $68.49 | $4,178.04 |
DisclosureSEC source: 0001562180-21-000753 · primarydocument.xml · nonDerivative · entry 2 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,732 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 298 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,369 restricted stock units. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 00:56 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 44 | $67.93 | $2,988.91 |
DisclosureSEC source: 0001562180-21-000753 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,793 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 298 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,369 restricted stock units. Read SEC document |
| January 25, 2021 Filed Jan 25, 2021 16:01 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,500 | $78.21 | $117,314.10 |
DisclosureSEC source: 0001562180-21-000502 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005,788 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $78.06 to $78.33. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 25, 2021 Filed Jan 25, 2021 16:01 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,500 | $77.64 | $271,741.75 |
DisclosureSEC source: 0001562180-21-000502 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,007,288 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $77.06 to $78.02. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 22, 2021 Filed Jan 22, 2021 23:47 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $79.29 | $132,176.43 |
DisclosureSEC source: 0001562180-21-000487 · primarydocument.xml · nonDerivative · entry 1 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,473 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 11,389 restricted stock units. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 19:55 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 1,000 | $76.36 | $76,361.00 |
DisclosureSEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,010,788 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $76.11 to $76.68. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 19:55 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 950 | $75.08 | $71,322.49 |
DisclosureSEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,011,788 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $74.53 to $75.35. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 19:55 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,050 | $73.76 | $224,962.82 |
DisclosureSEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,012,738 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $73.47 to $74.30. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 29,162 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · derivative · entry 11 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,951 Underlying: Common Stock · 29,162 shares Expires 2027-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests as to 25% of the shares on March 13, 2018 and vests as to an additional 2.083% of the shares per month thereafter until February 28, 2021. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · derivative · entry 10 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,900 shares Expires 2028-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $18.24 | $0.00 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · derivative · entry 9 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,900 shares Expires 2029-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
SaleCommon Stock | 8,199 | $51.08 | $418,822.14 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 8 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,080 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $50.79 to $51.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
SaleCommon Stock | 4,400 | $50.38 | $221,657.48 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 7 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,279 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $49.79 to $50.78. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
SaleCommon Stock | 2,333 | $49.16 | $114,681.88 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 6 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,679 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $48.74 to $49.70. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
SaleCommon Stock | 22,830 | $47.87 | $1,092,760.23 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 5 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,012 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $47.47 to $48.43. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
SaleCommon Stock | 7,200 | $47.17 | $339,592.32 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 4 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,842 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $46.47 to $47.46. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionCommon Stock | 29,162 | $8.16 | $237,961.92 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 3 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionCommon Stock | 7,900 | $14.80 | $116,920.00 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 2 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 17:01 UTC |
DEKKERS MARIJN EDirector
|
Exercise / conversionCommon Stock | 7,900 | $18.24 | $144,096.00 |
DisclosureSEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 1 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 16:21 UTC |
Fry John JGeneral Counsel & Secretary
|
SaleCommon Stock | 153 | $44.13 | $6,752.15 |
DisclosureSEC source: 0001562180-21-000187 · primarydocument.xml · nonDerivative · entry 1 Fry John J · CIK 0001419544 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,885 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 468 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 24,744 restricted stock units. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 16:21 UTC |
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
|
SaleCommon Stock | 3,510 | $44.13 | $154,902.27 |
DisclosureSEC source: 0001562180-21-000186 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,015,788 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:21 UTC |
Mattoon DawnSr. VP, Research Products
|
SaleCommon Stock | 170 | $44.13 | $7,502.39 |
DisclosureSEC source: 0001562180-21-000185 · primarydocument.xml · nonDerivative · entry 1 Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,016 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 518 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 20,340 restricted stock units. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:23 UTC |
Chaubal AmolChief Financial Officer
|
SaleCommon Stock | 124 | $44.13 | $5,472.33 |
DisclosureSEC source: 0001562180-21-000190 · primarydocument.xml · nonDerivative · entry 1 Chaubal Amol · CIK 0001773089 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 380 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 19,561 restricted stock units. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:21 UTC |
Roskey Mark T.SVP, Commercial & Accelerator
|
SaleCommon Stock | 98 | $44.13 | $4,324.91 |
DisclosureSEC source: 0001562180-21-000184 · primarydocument.xml · nonDerivative · entry 1 Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,837 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 298 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 14,667 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 18:22 UTC |
Hlavinka Sarah E.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $44.11 | $0.00 |
DisclosureSEC source: 0001562180-21-000114 · primarydocument.xml · derivative · entry 3 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2031-01-04 F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 18:22 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 269 | $44.11 | $11,865.59 |
DisclosureSEC source: 0001562180-21-000114 · primarydocument.xml · nonDerivative · entry 2 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,268 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021. F2 · balance_after: Includes 5,297 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 18:22 UTC |
Hlavinka Sarah E.Director
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000114 · primarydocument.xml · nonDerivative · entry 1 Hlavinka Sarah E. · CIK 0001433554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,999 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 5,297 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:54 UTC |
Madaus Martin DDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001562180-21-000099 · primarydocument.xml · derivative · entry 4 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2031-01-04 F6 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:54 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 410 | $44.11 | $18,085.10 |
DisclosureSEC source: 0001562180-21-000099 · primarydocument.xml · nonDerivative · entry 2 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,396 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:54 UTC |
Madaus Martin DDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000099 · primarydocument.xml · nonDerivative · entry 1 Madaus Martin D · CIK 0001310268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,986 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:45 UTC |
MEISTER PAUL MDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001562180-21-000098 · primarydocument.xml · derivative · entry 3 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2031-01-04 F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:45 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 311 | $44.11 | $13,718.21 |
DisclosureSEC source: 0001562180-21-000098 · primarydocument.xml · nonDerivative · entry 2 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,207 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:45 UTC |
MEISTER PAUL MDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000098 · primarydocument.xml · nonDerivative · entry 1 MEISTER PAUL M · CIK 0001033876 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,896 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 18:12 UTC |
WALT DAVID RDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001562180-21-000113 · primarydocument.xml · derivative · entry 2 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2031-01-04 F3 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 18:12 UTC |
WALT DAVID RDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000113 · primarydocument.xml · nonDerivative · entry 1 WALT DAVID R · CIK 0001205236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278,644 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 18:08 UTC |
DEKKERS MARIJN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001562180-21-000112 · primarydocument.xml · derivative · entry 2 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2031-01-04 F3 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 18:08 UTC |
DEKKERS MARIJN EDirector
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000112 · primarydocument.xml · nonDerivative · entry 1 DEKKERS MARIJN E · CIK 0001216068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,080 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:04 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001562180-21-000111 · primarydocument.xml · derivative · entry 5 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2031-01-04 F7 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:04 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 197 | $44.11 | $8,689.67 |
DisclosureSEC source: 0001562180-21-000111 · primarydocument.xml · nonDerivative · entry 2 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,426 F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020. F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:04 UTC |
CRANDELL KEITHDirector · 10% owner
|
GrantCommon Stock | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-000111 · primarydocument.xml · nonDerivative · entry 1 CRANDELL KEITH · CIK 0001219039 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,229 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 2,270 restricted stock units. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 22:03 UTC |
Duffy David C.SVP R&D and CTO
|
Exercise / conversionStock Option (Right to buy) · Derivative | 1,630 | $0.00 Strike: $2.28 | $0.00 |
DisclosureSEC source: 0001562180-20-007392 · primarydocument.xml · derivative · entry 3 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,023 Underlying: Common Stock · 1,630 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option is fully vested. Read SEC document |
| December 18, 2020 Filed Dec 21, 2020 22:03 UTC |
Duffy David C.SVP R&D and CTO
|
SaleCommon Stock | 1,667 | $43.82 | $73,047.94 |
DisclosureSEC source: 0001562180-20-007392 · primarydocument.xml · nonDerivative · entry 2 Duffy David C. · CIK 0001724566 · SVP R&D and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,140 F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020. F2 · balance_after: Includes 11,620 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.